Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Inpatient Screening Mammography for Non-adherent and High Risk Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04164251
Recruitment Status : Completed
First Posted : November 15, 2019
Last Update Posted : December 3, 2019
Sponsor:
Collaborators:
Maryland Cigarette Restitution Research Grant
EQUIP (Excellence in Quality, Utilization of resources, Integration and Patient- centered Care)
Information provided by (Responsible Party):
Johns Hopkins University

Brief Summary:
The investigators propose to pilot a program that will evaluate the feasibility of an inpatient screening mammography for non-adherent and high risk hospitalized women age 52-74 admitted to the medicine services at Johns Hopkins Bayview Medical Center and Howard County General Hospital. The two key activities include: inpatient breast care education with educational handouts and offering inpatient screening mammography. Inpatient screening mammography will be offered to non-adherent (last screening mammogram more than 24 months ago) and high risk (Gail 5-year risk of breast cancer 1.6 or greater) women. This pilot program will thus evaluate the feasibility of an inpatient screening mammography as an innovative approach to increase breast cancer screening among non-adherent and high risk women.

Condition or disease Intervention/treatment Phase
Breast Cancer Other: Screening mammography Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 101 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Inpatient Screening Mammography for Non-adherent and High Risk Women
Actual Study Start Date : January 2015
Actual Primary Completion Date : October 2016
Actual Study Completion Date : December 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Inpatient screening mammography for non-adherent and high risk
All non-adherent women were offered inpatient screening mammography during hospitalization
Other: Screening mammography
The purpose of the study was to evaluate the feasibility of securing inpatient breast cancer screening mammograms for non-adherent hospitalized women prior to hospital discharge.




Primary Outcome Measures :
  1. Proportion of women who underwent a screening mammography during hospitalization [ Time Frame: Prior to hospital discharge, up to 1 year ]
    Screening mammography is done during hospitalization. Proportion of women that get the screening will be assessed.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 74 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   women between 50 and 74 years of age who were non-adherent to breast screening guidelines (USPSTF recommendations)
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • women between 50 and 74 years of age who were non-adherent to breast screening guidelines

Exclusion Criteria:

  • Patients with a history of breast cancer or mastectomy
  • history of other cancers (except skin)
  • serious comorbidities making patient's life expectancy <10 years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04164251


Sponsors and Collaborators
Johns Hopkins University
Maryland Cigarette Restitution Research Grant
EQUIP (Excellence in Quality, Utilization of resources, Integration and Patient- centered Care)
Investigators
Layout table for investigator information
Principal Investigator: Waseem Khaliq, MD Johns Hopkins University

Layout table for additonal information
Responsible Party: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT04164251    
Other Study ID Numbers: NA_00079826
First Posted: November 15, 2019    Key Record Dates
Last Update Posted: December 3, 2019
Last Verified: November 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Johns Hopkins University:
Breast Cancer Screening
Mammography
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases